Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:23 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 343 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intracranial Hemorrhage Clear all

Conditions: Ischemic Stroke, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Dementia, Vascular, Mild Cognitive Impairment, Vascular Cognitive Impairment
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 8,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 31
States / cities: Phoenix, Arizona • Los Angeles, California • San Diego, California + 24 more

Conditions: Traumatic Brain Injury, Subarachnoid Hemorrhage
Interventions: Bedside display of cerebral perfusion pressure information; Other
Lead sponsor: University of Washington; Other
Eligibility: Not listed
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2008
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Fever, Brain Hemorrhage
Interventions: Gaymar Rapr-Round (external cooling blanket); Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Subarachnoid Hemorrhage, Anxiety, Pain, Delirium, Sleep
Interventions: Massage; Other
Lead sponsor: Sara E. Hocker, M.D; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cerebrovascular Disease, Ischemic Stroke, Transient Ischemic Attack, Intracerebral Hemorrhage, Aneurysmal Subarachnoid Hemorrhage, Vascular Dementia, Anoxic Brain Injury, Unruptured Intracranial Aneurysm, Carotid Artery Stenosis Symptomatic, Asymptomatic Carotid Artery Stenosis, Non-Aneurysmal Perimesencephalic Subarachnoid Haemorrhage, Cerebral Venous Thrombosis, Moyamoya Disease, Fibromuscular Dysplasia, Subarachnoid Hemorrhage, Leukoaraiosis, Arteriovenous Fistula, Reversible Cerebral Vasoconstriction Syndrome, CADASIL
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2030
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Cerebral Vasospasm
Interventions: Nicardipine, Verapamil, Nicardipine + Verapamil + Nitroglycerin; Drug
Lead sponsor: Peng Roc Chen, MD; Other
Eligibility: 18 Years to 80 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 5
States / cities: New Haven, Connecticut • Manhasset, New York • Winston-Salem, North Carolina + 2 more

Conditions: Acute Intracranial Hemorrhage
Interventions: andexanet alfa, Usual Care; Drug
Lead sponsor: Alexion Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 530 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 11
States / cities: Fort Lauderdale, Florida • Augusta, Georgia • Royal Oak, Michigan + 7 more

Conditions: Subarachnoid Hemorrhage, Aneurysmal
Interventions: tirofiban hydrochloride (AGGRASTAT®), MRI, Neurological Exam, Questionnaires, Vital Signs, Standard of Care Treatment; Drug · Diagnostic Test · Behavioral + 1 more
Lead sponsor: David Hasan; Other
Eligibility: 18 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Myocardial Depression, Takotsubo Syndrome, Subarachnoid Hemorrhage, Acute Ischemic Stroke
Interventions: Not listed
Lead sponsor: Ohio State University; Other
Eligibility: 50 Years and older · Female only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Traumatic Brain Injury
Interventions: Optic Nerve Ultrasounds; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Intracerebral Hemorrhage
Interventions: rt-PA; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 499 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 56
States / cities: Birmingham, Alabama • Phoenix, Arizona • Carmichael, California + 46 more

Conditions: Chronic Subdural Hematoma
Interventions: Conventional Surgery, Middle Meningeal Artery Embolization (MMAE); Procedure · Device
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 40 Years to 90 Years
Enrollment: 520 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 31
States / cities: Phoenix, Arizona • Jacksonville, Florida • Miami, Florida + 26 more

Conditions: Subarachnoid Hemorrhage, Cerebral Vasospasm, Cerebral Aneurysm, Hydrocephalus
Interventions: Tissue Plasminogen Activator; Drug
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hemorrhage; Intracerebral, Nontraumatic, Ischemic Strokes, Diffusion Weighted Imaging Lesions
Interventions: Not listed
Lead sponsor: Rush University Medical Center; Other
Eligibility: 19 Years to 79 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stroke, Neurologic Diseases, General
Interventions: NC-758 (Anti amyloidotic [Aß] agent); Drug
Lead sponsor: Bellus Health Inc. - a GSK company; Industry
Eligibility: 55 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 5
States / cities: Lexington, Kentucky • Boston, Massachusetts • New York, New York + 2 more

Conditions: Sars-CoV2, Severe Neurologic Injury, Ischemic Stroke, Hemorrhagic Stroke, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Traumatic Brain Injury, Status Epilepticus
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Subarachnoid Hemorrhage, Headache
Interventions: Regional anesthetic SPG block-bilateral; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Aneurysmal Subarachnoid Hemorrhage, Vasospasm, Cerebral, Transcutaneous Vagal Nerve Stimulation (tVNS), Endovascular Treatment
Interventions: Transcutaneous Vagal Nerve Stimulation; Device
Lead sponsor: Marshall Holland; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Subarachnoid Hemorrhage, Aneurysmal, Headache, Opiate Dependence, Opioid Use
Interventions: Lidocaine, Lidocaine and Dexamethasone; Drug
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 100 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Subarachnoid Hemorrhage
Interventions: Auricular Vagus Nerve Stimulation, Sham Auricular Vagus nerve Stimulation; Device
Lead sponsor: Anna Huguenard; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hypertension, Hemorrhage
Interventions: clevidipine; Drug
Lead sponsor: The Medicines Company; Industry
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 14
States / cities: Washington D.C., District of Columbia • Honolulu, Hawaii • Baltimore, Maryland + 11 more

Conditions: Acute, Non-traumatic Subarachnoid Hemorrhage, Intraparenchymal Hemorrhage, Brain Injuries
Interventions: Insulin, Conventional insulin treatment; Drug
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 80 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2015
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Cerebral Vasospasm After Subarachnoid Hemorrhage
Interventions: Dantrolene; Drug
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 2
States / cities: Boston, Massachusetts • Worcester, Massachusetts

Conditions: Subarachnoid Hemorrhage, Intracranial Hemorrhage, Ischemic Strokes, Subdural Hematoma
Interventions: Glycerna, Jevity - Control Diet; Dietary Supplement
Lead sponsor: Eastern Virginia Medical School; Other
Eligibility: 18 Years to 89 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Norfolk, Virginia

Search by objective public record fields.

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

Cerebral Perfusion Pressure (CPP) Management Information Feedback and Nursing

Temperature Control in Central Fever in the Neuro-ICU

Massage Technique for Pain, Anxiety and Delirium in SAH Patients

Florida Cerebrovascular Disease Biorepository and Genomics Center

The Intra-arterial Vasospasm Trial

Trial of Andexanet Alfa in ICrH Patients Receiving an Oral FXa Inhibitor

Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM)

Predicting the Development of Myocardial Depression in Acute Neurological Patients

In-Field Detection of Intracranial Pressure

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study

Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage

Effect of Ischemic Strokes on Recovery From Intracerebral Hemorrhages

Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy

COVID-19 Brain Injury

Efficacy of Percutaneous SPG Block in Aneurysmal SAH

The Effect of Transcutaneous Vagal Nerve Stimulation (tVNS) on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage

Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage

Auricular VNS Following Subarachnoid Hemorrhage

Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)

Normoglycemia and Neurological Outcome

Safety Study of Dantrolene to Treat Cerebral Vasospasm After Subarachnoid Hemorrhage

Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study